The Effect and Application of Adiponectin in Hepatic Fibrosis

Overview

Journal Gastroenterol Rep (Oxf)

Specialty Gastroenterology

Date 2024 Dec 31

PMID 39737222

Authors

Taoran Chen

Wenjing Yang

Rongrong Dong

Han Yao

Miao Sun

Jiaxin Wang

Qi Zhou

Jiancheng Xu

Affiliations

Soon will be listed here.

Abstract

Hepatic fibrosis, a degenerative liver lesion, significantly contributes to the deterioration and mortality among patients with chronic liver diseases. The condition arises from various factors including toxins, such as alcohol, infections like different types of viral hepatitis, and metabolic diseases. Currently, there are no effective treatments available for liver fibrosis. Recent research has shown that adiponectin (ADPN) exhibits inhibitory effects on hepatic fibrosis. ADPN, an adipocytokine secreted by mature adipocytes, features receptors that are widely distributed across multiple tissues, especially the liver. In the liver, direct effects of ADPN on liver fibrosis include reducing inflammation and regulating hepatic stellate cell proliferation and migration. And its indirect effects include alleviating hepatic endoplasmic reticulum stress and reducing inflammation in hepatic lobules, thereby mitigating hepatic fibrosis. This review aims to elucidate the regulatory role of ADPN in liver fibrosis, explore how ADPN and its receptors alleviate endoplasmic reticulum stress, summarize ADPN detection methods, and discuss its potential as a novel marker and therapeutic agent in combating hepatic fibrosis.

Citing Articles

Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn's Disease Patients.

Marra M, Mallardo M, Nigro E, Cioffi I, Leo C, Guarino A Biomedicines. 2025; 13(2).

PMID: 40002687 PMC: 11853605. DOI: 10.3390/biomedicines13020273.

References

Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N . Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000; 96(5):1723-32. View

Bennett W, Maruthur N, Singh S, Segal J, Wilson L, Chatterjee R . Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med. 2011; 154(9):602-13. PMC: 3733115. DOI: 10.7326/0003-4819-154-9-201105030-00336. View

Wolf A, Wolf D, Rumpold H, Enrich B, Tilg H . Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004; 323(2):630-5. DOI: 10.1016/j.bbrc.2004.08.145. View

Chen L, Liu W, Lai S, Li Y, Wang X, Zhang H . Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients. Eur J Gastroenterol Hepatol. 2013; 25(8):935-41. DOI: 10.1097/MEG.0b013e32835fa988. View

Korah T, El-Sayed S, Elshafie M, Hammoda G, Safan M . Significance of serum leptin and adiponectin levels in Egyptian patients with chronic hepatitis C virus associated hepatic steatosis and fibrosis. World J Hepatol. 2013; 5(2):74-81. PMC: 3642726. DOI: 10.4254/wjh.v5.i2.74. View

da Silva T, Costa-Silva M, Correa C, Denardin G, Alencar M, Coelho M . Clinical Significance of Serum Adiponectin and Resistin Levels in Liver Cirrhosis. Ann Hepatol. 2018; 17(2):286-299. DOI: 10.5604/01.3001.0010.8659. View

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

Khoramipour K, Chamari K, Hekmatikar A, Ziyaiyan A, Taherkhani S, Elguindy N . Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition. Nutrients. 2021; 13(4). PMC: 8066826. DOI: 10.3390/nu13041180. View

Lim J, Templeton S . Regulation of lung inflammation by adiponectin. Front Immunol. 2023; 14:1244586. PMC: 10505393. DOI: 10.3389/fimmu.2023.1244586. View

10.

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

11.

Ajoolabady A, Kaplowitz N, Lebeaupin C, Kroemer G, Kaufman R, Malhi H . Endoplasmic reticulum stress in liver diseases. Hepatology. 2022; 77(2):619-639. PMC: 9637239. DOI: 10.1002/hep.32562. View

12.

Putz D, Goldner W, Bar R, Haynes W, Sivitz W . Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy. Metabolism. 2004; 53(11):1454-61. DOI: 10.1016/j.metabol.2004.06.013. View

13.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

14.

Ma L, Li X, Bai Z, Lin X, Lin K . AdipoRs- a potential therapeutic target for fibrotic disorders. Expert Opin Ther Targets. 2018; 23(2):93-106. DOI: 10.1080/14728222.2019.1559823. View

15.

Thomas M, Nikooienejad A, Bray R, Cui X, Wilson J, Duffin K . Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. J Clin Endocrinol Metab. 2020; 106(2):388-396. PMC: 7823251. DOI: 10.1210/clinem/dgaa863. View

16.

Berg A, Combs T, Scherer P . ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002; 13(2):84-9. DOI: 10.1016/s1043-2760(01)00524-0. View

17.

Esmaili S, Hemmati M, Karamian M . Physiological role of adiponectin in different tissues: a review. Arch Physiol Biochem. 2018; 126(1):67-73. DOI: 10.1080/13813455.2018.1493606. View

18.

Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M . Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med. 2007; 13(3):332-9. DOI: 10.1038/nm1557. View

19.

Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K . PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001; 50(9):2094-9. DOI: 10.2337/diabetes.50.9.2094. View

20.

Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T . Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Hepatology. 2008; 48(2):458-73. DOI: 10.1002/hep.22365. View